Pharmaceutical
Indications

 

39 Results were found on Technologies

Leading Researchers:
10-2007-103

Improved Calcitonin-based Therapeutics

TechnologyThe aggregation site on human calcitonin has been identified, paving the way for development of specific inhibitors of calcitonin amyloid fibril formation. Such inhibitors will enable development of improved calcitonin therapeutics as... Read More >

Leading Researchers:
2-2011-142

IAPP Oligomers as a Target for Type 2 Diabetes Novel Immunotherapy

TechnologyStabilized human IAPP (hIAPP) oligomers were used for the development of active immunization of type 2 diabetes. This promising novel approach for the treatment of type 2 diabetes is doable due to the establishment of a new protocol for... Read More >

Leading Researchers:
5-2011-178

Quantitative confluency measurement of culture growth

The invention is an image processing method of light microscopy images for the purpose of quantifying density of cells in cultures . A grayscale image of a cell culture is digitally captured using a light microscope and a CCD camera... Read More >

Leading Researchers:
5-2011-249

METHODS AND KITS FOR DETERMINING PREDISPOSITION TO DEVELOP KIDNEY DISEASES

Many rare kidney disorders exhibit a monogenic, Mendelian pattern of inheritance. Population-based genetic studies have identified many genetic variants associated with an increased risk of developing common kidney diseases. Strongly associated... Read More >

Leading Researchers:
5-2007-42

Non-invasive Diagnostics for Liver Diseases

The Technology The human asialoglycoprotein receptor (ASGPR) is expressed on the sinusoidal membrane of hepatocytes and serves in the clearance of asialoglycoproteins from the plasma. A soluble form of the ASGPR, termed sH2a, is formed by... Read More >

Leading Researchers:
10-2020-1438

Plant-Derived Anti- Herpesvirus Composition

Herpes simplex virus infection is commonly known as herpes. The two types of herpes simplex virus are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic... Read More >

10-2008-86

Targeting Bone Neoplasms and Other Cancers with Novel Combined Anticancer and Anti-Angiogenic Polymer Therapeutics

Anti-cancer NanoTherapyUtilizing unique nano-technology to develop targeted combination nanomedicines that were shown to be synergistic, effective and safe for treating cancer TechnologyWe have developed a new platform technology for the... Read More >

Leading Researchers:
2-2016-1039

Development of Alzheimer Disease therapy based on counteracting the pathological effects of ApoE4

Alzheimer’s disease (AD) is the most common cause of dementia and is the outcome of progressive brain cells death. Due to the disorder’s heterogeneity and in view of the variety of pathological mechanisms inducing the disease we... Read More >

2-2019-1277

An Effective Sema3A Antibody as a Therapy for Optic Nerve Neurodegenerative Diseases

Glaucoma and ischemic or neuro-degenerative diseases of the optic nerve lead to vision loss and blindness. These pathologies are associated with progressive apoptosis of the retinal ganglion cells (RGC), a process which involves expression of... Read More >

Leading Researchers:
2-2021-1708

A Novel Modular Platform for Targeted RNA Therapeutics

This cutting edge technology comprises of Lipid Nanoparticles (LNPs), that emerged as one of the most advanced and efficient nucleic acids delivery platform, that are non-covalently coated with targeting antibodies via a recombinant protein... Read More >